Ascend Wellness Holdings (AAWH) Capital Expenditures (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Capital Expenditures of $5.2 million for Q1 2026, up 31.21% year-over-year from $3.9 million in Q1 2025, and up 130.53% quarter-over-quarter from -$17.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Capital Expenditures (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Capital Expenditures history runs 7 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 31.21% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $3.4 million (down 87.12% YoY), while the FY2025 annual figure was $2.1 million, down 90.47% from the prior year.
- Capital Expenditures for Q1 2026 stood at $5.2 million, up from -$17.0 million in the prior quarter.
- The five-year high for Capital Expenditures was $21.8 million in Q4 2024, with the low at -$17.0 million in Q4 2025.
- The 5-year median for Capital Expenditures is $541000.0 (2024), against an average of $2.5 million.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures surged 95400.0% in 2023, then slumped 177.92% in 2025.
- Ascend Wellness Holdings' Capital Expenditures stood at $7.0 million in 2022, then tumbled by 105.19% to -$364000.0 in 2023, then soared by 6082.14% to $21.8 million in 2024, then plunged by 177.92% to -$17.0 million in 2025, then surged by 130.53% to $5.2 million in 2026.
- Business Quant data shows AAWH's Capital Expenditures at $5.2 million in Q1 2026, -$17.0 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ascend Wellness Holdings | 95.41 Mn | 28.41 Mn | 45.49 Mn | 5.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.78 Mn |
| Jun 30, 2026 | 5.78 Mn |
| Mar 31, 2026 | 5.18 Mn |
| Mar 31, 2026 | 5.18 Mn |
| Dec 31, 2025 | -16.97 Mn |
| Dec 31, 2025 | -16.97 Mn |
| Sep 30, 2025 | 6.45 Mn |
| Sep 30, 2025 | 6.45 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Dec 31, 2024 | 21.78 Mn |
| Dec 31, 2024 | 21.78 Mn |
| Sep 30, 2024 | 541,000.00 |
| Sep 30, 2024 | 541,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Mar 31, 2024 | 241,000.00 |